Clinical Trials Browser

Phase 2 × Completed × Carcinoma, Adenoid Cystic × Clear all

NCT06521775 2025-09-12

An Investigational Scan (Ga-68 PSMA-11 PET/CT) for the Detection of Therapy Response in Patients With Metastatic Adenoid Cystic Carcinoma

Phase 2 Completed

Carcinoma, Adenoid Cystic

NCT02098538 2025-09-10

Regorafenib in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma

Phase 2 Completed

38 enrolled 10 charts

Carcinoma, Adenoid Cystic

NCT03274414 2025-05-16

A Clinical Trial of Endoscopic Surgery Followed by Chemotherapy and Proton Radiation for the Treatment of Tumors in the Sinus and Nasal Passages

Phase 2 Completed

3 enrolled 4 charts

Adenocarcinoma, Carcinoma, Squamous Cell, Carcinoma, Adenoid Cystic, Paranasal Sinus Neoplasms, Esthesioneuroblastoma, Olfactory

NCT03691207 2024-01-31

ACCURACY

Phase 2 Completed

87 enrolled 12 charts

Carcinoma, Adenoid Cystic

NCT04291300 2023-05-10

LUPSA

Phase 2 Completed

Carcinoma, Adenoid Cystic, Salivary Gland Neoplasms

NCT03999684 2023-01-23

A Trial of All-trans Retinoic Acid (ATRA) in Advanced Adenoid Cystic Carcinoma

Phase 2 Completed

18 enrolled 8 charts

Carcinoma, Adenoid Cystic

NCT03087019 2022-10-14

Pembrolizumab With or Without Radiation in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma

Phase 2 Completed

21 enrolled 11 charts

Carcinoma, Adenoid Cystic

NCT03639168 2021-08-19

Chidamide Combined With Cisplatin in Head and Neck Adenoid Cystic Carcinoma (HNACC)

Phase 2 Completed

Carcinoma, Adenoid Cystic

NCT01065844 2019-10-09

Nelfinavir in Recurrent Adenoid Cystic Cancer of the Head and Neck

Phase 2 Completed

15 enrolled 3 charts

Carcinoma, Adenoid Cystic, Head and Neck Neoplasms

NCT01524692 2018-11-09

ACC

Phase 2 Completed

35 enrolled 12 charts

Carcinoma, Adenoid Cystic

NCT01558661 2017-11-28

Axitinib (AG-013736) in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma

Phase 2 Completed

33 enrolled 10 charts

Carcinoma, Adenoid Cystic, Neoplasm Metastasis, Recurrence

NCT00154388 2016-11-18

Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases

Phase 2 Completed

BreastDermatologicGenitourinaryGynecologicLymphoidMyeloidOther hematologic neoplasmOther solid neoplasmPlasma cellSarcomaThoracic

Malignant mesenchymal tumor, Adenocarcinoma, Brenner Tumor, Carcinoma, Renal Cell, Chondrosarcoma, Chordoma, Carcinoma, Adenoid Cystic, Fibroma, Hemangiopericytoma, Hemangiosarcoma, Leiomyosarcoma, Leukemia, Mast-Cell, Liposarcoma, Mastocytosis, Melanoma, Mesothelioma, Multiple Myeloma, Pleural Neoplasms, Sarcoma, Ewing, Osteosarcoma, Sarcoma, Synovial, Thymoma, Hypereosinophilic Syndrome, Sarcoma, Endometrial Stromal, Dermatofibrosarcoma, Rhabdomyosarcoma, Embryonal, Seminoma, Carcinoma, Ductal, Breast, Neurofibrosarcoma, Primary Myelofibrosis, Small Cell Lung Carcinoma

NCT00581360 2016-11-07

Phase II Trial of Doxorubicin and Bortezomib in Patients With Incurable Adenoid Cystic Carcinoma of the Head and Neck

Phase 2 Completed

10 enrolled 8 charts

Carcinoma, Adenoid Cystic

NCT01152840 2015-05-20

ACCRAD001

Phase 2 Completed

Carcinoma, Adenoid Cystic

NCT01417143 2014-11-13

Dovitinib in Adenoid Cystic Carcinoma

Phase 2 Completed

Carcinoma, Adenoid Cystic